HealthyMEDITATIONNCT03117478
Brain and Mindfulness
A study testing Magneto-encephalography (MEG), Electro-encephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in people with Healthy, run by Hospices Civils de Lyon at 1 site in France.
Trial summary
The main aim of this project is to explore the neuro-anatomical and -physiological correlates of meditation on attention and emotion-regulation. By investigating this, our scientific goal is to more generally identify the mechanisms and biomarkers of health and mental well-being. Read more about this study
- Who is it for?
- Ages 25 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Magneto-encephalography (MEG), Electro-encephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 169 participants
- Where
- 1 siteFrance
- Study dates
- 19 Mar 2016to 16 Oct 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age : 25-70
- Being affiliated to a social security system.
- Motivated to participate in this study.
Who cannot join
- Medication acting on the central nervous system
- Opioids, Antidepressive Agents.
- Actual or previous neurological or psychiatric illnesses
- Chronic pain or any other medical condition which is related to pain or an increased sensitivity to pain.
- Not having a personal or family history of epilepsy
- Alcohol or drugs consumption 2 days before or during the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of Meditation Practice on Attention and Emotion Regulation :Studies on Neural Correlation in Brain Imagery and Biomarkers of Stress and Inflammation
The main aim of this project is to explore the neuro-anatomical and -physiological correlates of meditation on attention and emotion-regulation. By investigating this, our scientific goal is to more generally identify the mechanisms and biomarkers of health and mental well-being. Therefore, the investigators use non-invasive imaging like Magneto-EncephaloGraphy (MEG), ElectroEncephaloGraphy (EEG), functional and anatomic Magnetic Resonance Imaging (MRI; including Diffusion tensor - DTI). These brain measures will then be linked to behavioral measurements. Experimental methods (i.e., simple computer tasks) will be used to measure attention, conscious perception and regulation of pain and emotion.
- Conditions
- Healthy
- Being tested
- Magneto-encephalography (MEG), Electro-encephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Anatomical Magnetic Resonance Imaging (aMRI), Meditation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Magneto-encephalography (MEG)Other
Magneto-encephalography
Electro-encephalography (EEG)Other
Electro-encephalography
Functional Magnetic Resonance Imaging (fMRI)Other
Functional Magnetic Resonance Imaging
Anatomical Magnetic Resonance Imaging (aMRI)Other
Anatomical Magnetic Resonance Imaging
MeditationOther
Meditation
| Study group | Role | What they receive |
|---|---|---|
| 1. Participants without meditation experience | Other | Novices. Note that there is no meditation intervention in this study but that the two groups differ in their lifetime meditation experience. Receives: Other: Magneto-encephalography (MEG); Other: Electro-encephalography (EEG); Other: Functional Magnetic Resonance Imaging (fMRI); Other: Anatomical Magnetic Resonance Imaging (aMRI); Other: Meditation |
| 2. Participant with a significant meditation experience | Other | Experts : > 5000 hours of practice during their life. Note that there is no meditation intervention in this study but that the two groups differ in their lifetime meditation experience. Receives: Other: Magneto-encephalography (MEG); Other: Electro-encephalography (EEG); Other: Functional Magnetic Resonance Imaging (fMRI); Other: Anatomical Magnetic Resonance Imaging (aMRI); Other: Meditation |
| 3. Participants without meditation experience | Other | Novices. There is no meditation intervention during the study but the investigators investigate the effects of meditation by comparing 2 groups who differ in their life time meditation experience (i.e., novices vs. experts). Receives: Other: Magneto-encephalography (MEG); Other: Electro-encephalography (EEG); Other: Functional Magnetic Resonance Imaging (fMRI); Other: Anatomical Magnetic Resonance Imaging (aMRI) |
| 4. Participant with a significant meditation experience | Other | Experts : > 5000 hours of practice during their life. There is no meditation intervention during the study but the investigators investigate the effects of meditation by comparing 2 groups who differ in their life time meditation experience (i.e., novices vs. experts). Receives: Other: Magneto-encephalography (MEG); Other: Electro-encephalography (EEG); Other: Functional Magnetic Resonance Imaging (fMRI); Other: Anatomical Magnetic Resonance Imaging (aMRI) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anatomical MRI scan
Brain structure
Measured: Day 1
Functional MRI scan
Brain activation: Haemodynamic response - BOLD signal.
Measured: Day1
EEG
Event-related potential fields : amplitude in fT and latency in ms. Oscillations : power spectral density and time-frequency oscillations in fT^2/Hz
Measured: Day 1
Secondary outcomes (12)
Behavioral measure : Accuracy of the performed task actions
Participants will perform behavioral computer tasks in which accuracy and speed is important. Performance behavior will be measured in this task: Accuracy of the performed task actions: number of errors and hits
Measured: Day 1
Psychophysics: Pain threshold
Pain threshold: The threshold of pain or pain threshold is the point along a curve of increasing perception of a stimulus at which pain begins to be felt. The temperature in degrees Celcius at which heat becomes painful for a recipient.
Measured: Day 1
Psychophysiology : Respiration
Respiration rate: breaths/minute
Measured: Day 1
Subjective experience of the participant
Measured: Day 1
Studies biomarkers of inflammation
area of the inflamed site in mm^2, obtained by automatic image processing of a photography
Measured: Day 1
Behavioral measure : Speed of the performed task actions
Participants will perform behavioral computer tasks in which accuracy and speed is important. Performance behavior will be measured in this task: Speed of the performed task actions: in ms.
Measured: Day 1
Psychophysiology : Heart
Heart Rate: pulses/minute
Measured: Day 1
Psychophysiology : Heart rate variability
Heart rate variability (HRV): Using an electrocardiogram, the variation in the beat-to-beat interval; measured in ms.
Measured: Day 1
Psychophysiology : Muscles
Electromyography (EMG): Recording the electrical activity produced by muscles; measured in mV.
Measured: Day 1
Psychophysiology : Eyes
Eye gaze position: relative to center of the screen, in imm
Measured: Day 1
Psychophysiology : Pupillar response
Pupillar response: pupil diameter, in mm.
Measured: Day 1
Electrogastrogram
Recording the electrical signals that travel through the stomach muscles and control the muscles' contractions (waves/minute)
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Apr 2017
- Study start19 Mar 2016
- Primary completion16 Oct 2019
- Study completion16 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 169 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sandrine SONIE, MD, Principal investigator, Le Vinatier
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03117478
- Sponsor's protocol ID
- 69HCL16_0678
- Acronym
- MEDITATION
- Status last verified
- Sep 2025
- First submitted
- 8 Feb 2017
- Last updated
- 19 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Zorn J, Abdoun O, Sonie S, Lutz A. Cognitive Defusion Is a Core Cognitive Mechanism for the Sensory-Affective Uncoupling of Pain During Mindfulness Meditation. Psychosom Med. 2021 Jul-Aug 01;83(6):566-578. doi: 10.1097/PSY.0000000000000938.
PubMed 33790200Poublan-Couzardot A, Lecaignard F, Fucci E, Davidson RJ, Mattout J, Lutz A, Abdoun O. Time-resolved dynamic computational modeling of human EEG recordings reveals gradients of generative mechanisms for the MMN response. PLoS Comput Biol. 2023 Dec 13;19(12):e1010557. doi: 10.1371/journal.pcbi.1010557. eCollection 2023 Dec.
PubMed 38091350Poletti S, Abdoun O, Zorn J, Lutz A. Pain regulation during mindfulness meditation: Phenomenological fingerprints in novices and experts practitioners. Eur J Pain. 2021 Aug;25(7):1583-1602. doi: 10.1002/ejp.1774. Epub 2021 Apr 22.
PubMed 33797842Katyal S, Abdoun O, Mounier H, Lutz A. Reduced processing of afforded actions while observing mental content as ongoing mental phenomena. Sci Rep. 2024 May 2;14(1):10130. doi: 10.1038/s41598-024-60934-6.
PubMed 38698150Fucci E, Poublan-Couzardot A, Abdoun O, Lutz A. No effect of focused attention and open monitoring meditation on EEG auditory mismatch negativity in expert and novice practitioners. Int J Psychophysiol. 2022 Jun;176:62-72. doi: 10.1016/j.ijpsycho.2022.03.010. Epub 2022 Mar 28.
PubMed 35358612Fucci E, Abdoun O, Baquedano C, Lutz A. Ready to help, no matter what you did: Responsibility attribution does not influence compassion in expert Buddhist practitioners. J Exp Psychol Gen. 2024 Apr;153(4):1093-1111. doi: 10.1037/xge0001542. Epub 2024 Feb 22.
PubMed 38386366Czajko S, Zorn J, Daumail L, Chetelat G, Margulies DS, Lutz A. Exploring the Embodied Mind: Functional Connectome Fingerprinting of Meditation Expertise. Biol Psychiatry Glob Open Sci. 2024 Aug 9;4(6):100372. doi: 10.1016/j.bpsgos.2024.100372. eCollection 2024 Nov.
PubMed 39309211Zorn J, Abdoun O, Bouet R, Lutz A. Mindfulness meditation is related to sensory-affective uncoupling of pain in trained novice and expert practitioners. Eur J Pain. 2020 Aug;24(7):1301-1313. doi: 10.1002/ejp.1576. Epub 2020 May 7.
PubMed 32311185Fucci E, Abdoun O, Lutz A. Auditory perceptual learning is not affected by anticipatory anxiety in the healthy population except for highly anxious individuals: EEG evidence. Clin Neurophysiol. 2019 Jul;130(7):1135-1143. doi: 10.1016/j.clinph.2019.04.010. Epub 2019 Apr 27.
PubMed 31085447Abdoun O, Zorn J, Poletti S, Fucci E, Lutz A. Training novice practitioners to reliably report their meditation experience using shared phenomenological dimensions. Conscious Cogn. 2019 Feb;68:57-72. doi: 10.1016/j.concog.2019.01.004. Epub 2019 Jan 15.
PubMed 30658238
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Meditation Practice on Attention and Emotion Regulation :Studies on Neural Correlation in Brain Imagery and Biomarkers of Stress and Inflammation
- ClinicalTrials.gov ID
- NCT03117478
- Acronym / sponsor ID
- MEDITATION / 69HCL16_0678
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 169 participants (actual)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 19 Mar 2016 (actual)
- Primary completion
- 16 Oct 2019 (actual)
- Study completion
- 16 Oct 2019 (actual)
- First posted
- 18 Apr 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main aim of this project is to explore the neuro-anatomical and -physiological correlates of meditation on attention and emotion-regulation. By investigating this, our scientific goal is to more generally identify the mechanisms and biomarkers of health and mental well-being. Therefore, the investigators use non-invasive imaging like Magneto-EncephaloGraphy (MEG), ElectroEncephaloGraphy (EEG), functional and anatomic Magnetic Resonance Imaging (MRI; including Diffusion tensor - DTI). These brain measures will then be linked to behavioral measurements. Experimental methods (i.e., simple computer tasks) will be used to measure attention, conscious perception and regulation of pain and emotion.
Study design
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| 1. Participants without meditation experience | Other | Other: Magneto-encephalography (MEG), Other: Electro-encephalography (EEG), Other: Functional Magnetic Resonance Imaging (fMRI), Other: Anatomical Magnetic Resonance Imaging (aMRI), Other: MeditationNovices. Note that there is no meditation intervention in this study but that the two groups differ in their lifetime meditation experience. |
| 2. Participant with a significant meditation experience | Other | Other: Magneto-encephalography (MEG), Other: Electro-encephalography (EEG), Other: Functional Magnetic Resonance Imaging (fMRI), Other: Anatomical Magnetic Resonance Imaging (aMRI), Other: MeditationExperts : > 5000 hours of practice during their life. Note that there is no meditation intervention in this study but that the two groups differ in their lifetime meditation experience. |
| 3. Participants without meditation experience | Other | Other: Magneto-encephalography (MEG), Other: Electro-encephalography (EEG), Other: Functional Magnetic Resonance Imaging (fMRI), Other: Anatomical Magnetic Resonance Imaging (aMRI)Novices. There is no meditation intervention during the study but the investigators investigate the effects of meditation by comparing 2 groups who differ in their life time meditation experience (i.e., novices vs. experts). |
| 4. Participant with a significant meditation experience | Other | Other: Magneto-encephalography (MEG), Other: Electro-encephalography (EEG), Other: Functional Magnetic Resonance Imaging (fMRI), Other: Anatomical Magnetic Resonance Imaging (aMRI)Experts : > 5000 hours of practice during their life. There is no meditation intervention during the study but the investigators investigate the effects of meditation by comparing 2 groups who differ in their life time meditation experience (i.e., novices vs. experts). |
Who may qualify
- Ages
- 25 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age : 25-70
- Being affiliated to a social security system.
- Motivated to participate in this study.
Key exclusion criteria (6 listed)
- Medication acting on the central nervous system
- Opioids, Antidepressive Agents.
- Actual or previous neurological or psychiatric illnesses
- Chronic pain or any other medical condition which is related to pain or an increased sensitivity to pain.
- Not having a personal or family history of epilepsy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Magneto-encephalography (MEG)Magneto-encephalography | Other | 1. Participants without meditation experience, 2. Participant with a significant meditation experience, 3. Participants without meditation experience, 4. Participant with a significant meditation experience |
| Electro-encephalography (EEG)Electro-encephalography | Other | 1. Participants without meditation experience, 2. Participant with a significant meditation experience, 3. Participants without meditation experience, 4. Participant with a significant meditation experience |
| Functional Magnetic Resonance Imaging (fMRI)Functional Magnetic Resonance Imaging | Other | 1. Participants without meditation experience, 2. Participant with a significant meditation experience, 3. Participants without meditation experience, 4. Participant with a significant meditation experience |
| Anatomical Magnetic Resonance Imaging (aMRI)Anatomical Magnetic Resonance Imaging | Other | 1. Participants without meditation experience, 2. Participant with a significant meditation experience, 3. Participants without meditation experience, 4. Participant with a significant meditation experience |
| MeditationMeditation | Other | 1. Participants without meditation experience, 2. Participant with a significant meditation experience |
Primary outcome
Anatomical MRI scan
Time frame: Day 1
Brain structure
Functional MRI scan
Time frame: Day1
Brain activation: Haemodynamic response - BOLD signal.
EEG
Time frame: Day 1
Event-related potential fields : amplitude in fT and latency in ms. Oscillations : power spectral density and time-frequency oscillations in fT^2/Hz
12 secondary outcomes
Behavioral measure : Accuracy of the performed task actions
Time frame: Day 1
Psychophysics: Pain threshold
Time frame: Day 1
Psychophysiology : Respiration
Time frame: Day 1
Subjective experience of the participant
Time frame: Day 1
Studies biomarkers of inflammation
Time frame: Day 1
Behavioral measure : Speed of the performed task actions
Time frame: Day 1
Psychophysiology : Heart
Time frame: Day 1
Psychophysiology : Heart rate variability
Time frame: Day 1
Psychophysiology : Muscles
Time frame: Day 1
Psychophysiology : Eyes
Time frame: Day 1
Psychophysiology : Pupillar response
Time frame: Day 1
Electrogastrogram
Time frame: Day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2025.
- Background: PubMed 33790200Zorn J, Abdoun O, Sonie S, Lutz A. Cognitive Defusion Is a Core Cognitive Mechanism for the Sensory-Affective Uncoupling of Pain During Mindfulness Meditation. Psychosom Med. 2021 Jul-Aug 01;83(6):566-578. doi: 10.1097/PSY.0000000000000938.
- Background: PubMed 38091350Poublan-Couzardot A, Lecaignard F, Fucci E, Davidson RJ, Mattout J, Lutz A, Abdoun O. Time-resolved dynamic computational modeling of human EEG recordings reveals gradients of generative mechanisms for the MMN response. PLoS Comput Biol. 2023 Dec 13;19(12):e1010557. doi: 10.1371/journal.pcbi.1010557. eCollection 2023 Dec.
- Background: PubMed 33797842Poletti S, Abdoun O, Zorn J, Lutz A. Pain regulation during mindfulness meditation: Phenomenological fingerprints in novices and experts practitioners. Eur J Pain. 2021 Aug;25(7):1583-1602. doi: 10.1002/ejp.1774. Epub 2021 Apr 22.
- Background: PubMed 38698150Katyal S, Abdoun O, Mounier H, Lutz A. Reduced processing of afforded actions while observing mental content as ongoing mental phenomena. Sci Rep. 2024 May 2;14(1):10130. doi: 10.1038/s41598-024-60934-6.
- Background: PubMed 35358612Fucci E, Poublan-Couzardot A, Abdoun O, Lutz A. No effect of focused attention and open monitoring meditation on EEG auditory mismatch negativity in expert and novice practitioners. Int J Psychophysiol. 2022 Jun;176:62-72. doi: 10.1016/j.ijpsycho.2022.03.010. Epub 2022 Mar 28.
- Background: PubMed 38386366Fucci E, Abdoun O, Baquedano C, Lutz A. Ready to help, no matter what you did: Responsibility attribution does not influence compassion in expert Buddhist practitioners. J Exp Psychol Gen. 2024 Apr;153(4):1093-1111. doi: 10.1037/xge0001542. Epub 2024 Feb 22.
- Background: PubMed 39309211Czajko S, Zorn J, Daumail L, Chetelat G, Margulies DS, Lutz A. Exploring the Embodied Mind: Functional Connectome Fingerprinting of Meditation Expertise. Biol Psychiatry Glob Open Sci. 2024 Aug 9;4(6):100372. doi: 10.1016/j.bpsgos.2024.100372. eCollection 2024 Nov.
- Results publication: PubMed 32311185Zorn J, Abdoun O, Bouet R, Lutz A. Mindfulness meditation is related to sensory-affective uncoupling of pain in trained novice and expert practitioners. Eur J Pain. 2020 Aug;24(7):1301-1313. doi: 10.1002/ejp.1576. Epub 2020 May 7.
- Results publication: PubMed 31085447Fucci E, Abdoun O, Lutz A. Auditory perceptual learning is not affected by anticipatory anxiety in the healthy population except for highly anxious individuals: EEG evidence. Clin Neurophysiol. 2019 Jul;130(7):1135-1143. doi: 10.1016/j.clinph.2019.04.010. Epub 2019 Apr 27.
- Results publication: PubMed 30658238Abdoun O, Zorn J, Poletti S, Fucci E, Lutz A. Training novice practitioners to reliably report their meditation experience using shared phenomenological dimensions. Conscious Cogn. 2019 Feb;68:57-72. doi: 10.1016/j.concog.2019.01.004. Epub 2019 Jan 15.
Related trials for Healthy
Not yet recruitingPhase 1
Dynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium Contrast
Healthy Volunteers
RecruitingObservational study
Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
Healthy Volunteers
Active, not recruitingPhase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
Healthy
Not yet recruitingObservational study
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Blood Donors, Apheresis
Recruiting
Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals
Fatty Acids, Omega-3, Fish Oils
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sandrine SONIE, MD principal investigator
Le Vinatier
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Magneto-encephalography (MEG), Electro-encephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in people with Healthy, run by Hospices Civils de Lyon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anatomical MRI scan (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03117478, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.